Association of elevated interleukin-17 and angiopoietin-2 with prostate size in benign prostatic hyperplasia.

Introduction: Inflammation and angiogenesis are known to play a role in the development prostate tumors. The present study was designed to assess the levels of markers of inflammation and angiogenesis like interleukin-17 (IL-17) and angiopoietin-2 (ANGPT2) levels and their association with prostate size in patients with benign prostatic hyperplasia (BPH).

Materials And Methods: 42 BPH cases and 42 controls were enrolled in the study.